Inactive Instrument

Calendar Foamix Pharmaceuticals Ltd. Nasdaq

Equities

IL0011334385

Chart calendar Foamix Pharmaceuticals Ltd.

d840bef6d48cd0773d5e.84yXEpnpPyvAUtJ5PRdJT46Wr2x8VbKSDvm5DEtKnvE.m8nIXe27UHO3ZoAtDVg6K77-7h4wON6hWJDpVQMfz4SsxcJoqqRgRrchgw~f17dd8ff3d64e6dc7018e982efe5b01b

Upcoming events on Foamix Pharmaceuticals Ltd.

08/05/2024 Q1 2024 Earnings Release (Projected)
08/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Foamix Pharmaceuticals Ltd.

28/03/2024 12:30 H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
07/03/2024 17:06 Global Vitiligo Foundation Scientific Symposium
04/03/2024 15:30 TD Cowen Health Care Conference
29/02/2024 13:00 Q4 2023 Earnings Release
13/12/2023 15:00 Annual General Meeting
13/11/2023 12:45 Q3 2023 Earnings Release
09/11/2023 18:30 R&D Day
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
14/08/2023 13:00 Q2 2023 Earnings Release
04/06/2023 BIO International Convention
11/05/2023 21:01 Q1 2023 Earnings Release
30/03/2023 20:30 H.C. Wainwright Autoimmune & Inflammatory Disease Conference
09/03/2023 21:01 Q4 2022 Earnings Release
07/03/2023 19:10 Cowen Health Care Conference
12/01/2023 15:00 Extraordinary Shareholders Meeting
09/01/2023 LifeSci Partners Corporate Access Conference
09/01/2023 JP Morgan Healthcare Conference
08/12/2022 15:00 Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
01/12/2022 17:30 Piper Sandler Healthcare Conference
10/11/2022 21:01 Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,44
2,34
-81.04%
21,0
21,7
-3.3%
14,8
17,3
-14.51%
0,48
0,37
30.09%
0,42
0,50
-15.2%

0,40

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-29,3
-29,7
1.49%

-35,0

EBIT
Million USD
Released
Forecast
Spread
-95,9
-99,9
3.98%
-253
-190
-32.84%
-68,0
-65,9
-3.17%
-34,3
-36,6
6.17%
-29,3
-32,2
9%

-35,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-95,4
-99,3
3.97%
-256
-259
1.04%
-73,8
-72,2
-2.26%
-33,9
-30,3
-12.17%
-27,9
-28,7
2.89%

-33,5

Net income
Million USD
Released
Forecast
Spread
-95,2
-99,3
4.15%
-256
-258
1.03%
-73,3
-72,2
-1.63%
-23,2
-23,8
2.27%
-28,5
-28,7
0.86%

-33,5

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
-142
-121
-17.32%
-25,6
-24,7
-3.4%
-7,28
-8,52
14.55%
-2,78
-4,82
42.32%

-1,00

Announcement Date12/03/2004/03/2117/03/2209/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
2,29
4,12
-44.37%
0,18
0,37
-51.45%
0,13
0,10
26%
0,17
0,05
234%
0,01
0,06
-90%
0,10
0,00
-
0,14
0,05
170%
0,11
0,15
-24%
0,08
0,15
-49.33%

0,10


0,11


0,11


0,13

EBITDA
Million USD
Released
Forecast
Spread






















-10,8


-7,30


-8,10


-8,50


-8,90


-9,50

EBIT
Million USD
Released
Forecast
Spread
-12,0
-13,4
10.12%
-8,69
-8,67
-0.28%
-8,29
-9,77
15.15%
-9,33
-10,3
8.95%
-7,98
-10,3
22.49%
-5,88
-8,45
30.47%
-10,3
-10,6
2.66%


















Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,0
-13,5
10.65%
-8,69
-8,90
2.31%
-8,24
-10,3
20.05%
-9,26
-8,90
-3.99%
-7,75
-10,6
26.56%
-5,61
-8,40
33.19%
-10,0
-8,70
-15.38%
-6,07
-10,6
42.73%
-6,15
-7,00
12.11%

-7,80


-8,20


-8,50


-9,10

Net income
Million USD
Released
Forecast
Spread
-11,6
-13,5
13.98%
4,67
-8,90
152.47%
-8,48
-10,3
17.71%
-9,46
-8,90
-6.28%
-9,95
-10,6
5.73%
-5,62
-8,40
33.07%
-10,1
-8,70
-15.61%
-6,58
-10,6
37.89%
-6,19
-7,00
11.6%

-7,79


-8,20


-8,50


-9,10

EPS
USD
Released
Forecast
Spread
-3,96
-4,50
12%
1,44
-2,94
148.98%
-2,70
-3,24
16.67%
-2,88
-2,82
-2.13%
-3,33
-3,24
-2.78%
-1,74
-2,61
33.33%
-3,09
-2,58
-19.77%
-2,01
-0,76
-164.47%
-0,20
-0,50
60%

-0,24


-0,25


-0,25


-0,27

Announcement Date17/03/2212/05/2212/08/2210/11/2209/03/2311/05/2314/08/2313/11/2329/02/24----
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Stock
  5. Calendar Foamix Pharmaceuticals Ltd.